Stocks in play: XORTX Therapeutics Inc.
Announces that it has received TSX Venture Exchange approval to amend the terms of the balance of outstanding common share purchase warrants that were issued on October 15, 2021. XORTX Therapeutics Inc. shares V.XRTX are trading unchanged at $3.35.
Read:
Surge in AI Investments Promises Revolutionary Tools for White-Collar Work
Lithium's Future Looks Bright: Demand Expected to Surge by 1,500% by 2050 According to IEA Data
Biotech Innovations Drive Hope in Global Fight Against Pancreatic Cancer
Data Center Infrastructure Management Market on Track for Rapid Growth